We still need: Larger, long-term studies specifically focusing on psoriasis and PsA patients More data on optimal dosing and treatment duration Better understanding of how these drugs interact with current psoriasis and PsA treatments Empowering Your Psoriasis and PsA Management: Explore GLP-1 Options If you have psoriasis or PsA and struggle with weight management or treatment resistance, GLP-1 receptor agonists offer a new avenue for improving your condition
Unwin N, Shaw J, Zimmet P, Alberti KGMM
So a patient seeking to microdose the medication may take Ozempic at 0.25mg or 0.5mg per week, or 1mg every 10 days
Its glucagon receptor activation , though historically associated with hyperglycemia, is balanced by GLP-1 and GIP action , creating a net glycemic improvement
Ten patients received semaglutide 1.0 mg, and one patient each received semaglutide 0.5 mg, liraglutide 1.2 mg and liraglutide 2.4 mg (maximum tolerated dose)